Multiply-primed amplification of nucleic acid sequences

Details for Australian Patent Application No. 2001268725 (hide)

Owner Qiagen GmbH

Inventors Dean, Frank B.; Nelson, John; Lasken, Roger S.

Agent Davies Collison Cave

Pub. Number AU-B-2001268725

PCT Pub. Number WO02/00934

Priority 09/605,192 28.06.00 US

Filing date 27 June 2001

Wipo publication date 8 January 2002

Acceptance publication date 3 August 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

20 July 2006 Assignment before Grant

  Molecular Staging Inc. The application has been assigned to Qiagen GmbH 2002

3 August 2006 Application Accepted

  Published as AU-B-2001268725

30 November 2006 Standard Patent Sealed

7 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001268726

2001268724-Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immunesuppressive agents